25.19
price up icon0.88%   0.22
after-market Handel nachbörslich: 25.19
loading
Schlusskurs vom Vortag:
$24.97
Offen:
$25.09
24-Stunden-Volumen:
487.90K
Relative Volume:
2.29
Marktkapitalisierung:
$1.37B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.56%
1M Leistung:
+0.12%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$24.31
$26.00
1-Wochen-Bereich:
Value
$22.55
$26.00
52-Wochen-Spanne:
Value
$18.33
$27.94

Bicara Therapeutics Inc Stock (BCAX) Company Profile

Name
Firmenname
Bicara Therapeutics Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
BCAX's Discussions on Twitter

Bicara Therapeutics Inc Aktie (BCAX) Neueste Nachrichten

pulisher
11:31 AM

Bicara Therapeutics stock gets Buy rating from H.C. Wainwright on asset - Investing.com

11:31 AM
pulisher
07:49 AM

Bicara Therapeutics (NASDAQ:BCAX) Coverage Initiated at Rodman & Renshaw - MarketBeat

07:49 AM
pulisher
Oct 23, 2024

Biocon Stole Licensed Cancer Biotech to Fuel Spinoff, Suit Says - Bloomberg Law

Oct 23, 2024
pulisher
Oct 16, 2024

Balance Sheet Breakdown: Bicara Therapeutics Inc. (BCAX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Oct 16, 2024
pulisher
Oct 11, 2024

In the Green: Bicara Therapeutics Inc. (BCAX) Closes at 19.00, Up/Down -6.40 from Previous Day - The Dwinnex

Oct 11, 2024
pulisher
Oct 10, 2024

Down rounds don’t aid post-IPO performance - BioCentury

Oct 10, 2024
pulisher
Oct 08, 2024

Bicara shares initiated with Buy on cancer drug potential By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Bicara stock poised for growth with late-stage transition, Morgan Stanley optimistic - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Bicara Therapeutics stock sees upside with lead drug potential, says Stifel - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Bicara shares initiated with Buy on cancer drug potential - Investing.com India

Oct 08, 2024
pulisher
Oct 08, 2024

Cantor Fitzgerald starts Bicara Therapeutics with Overweight rating - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Cantor Fitzgerald starts Bicara Therapeutics with Overweight rating By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Bicara Therapeutics stock sees upside with lead drug potential, says Stifel By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 07, 2024

Three startups aim to raise $400 mln as US biotech IPOs gain traction - Reuters

Oct 07, 2024
pulisher
Oct 04, 2024

Bicara Leads Trio of US Biotech IPOs Raising $703 Million - MSN

Oct 04, 2024
pulisher
Oct 02, 2024

Market Update: Bicara Therapeutics Inc. (BCAX) Sees Negative Movement, Closing at 24.43 - The Dwinnex

Oct 02, 2024
pulisher
Sep 27, 2024

Bicara Therapeutics, Adecoagro, and More Stocks See Action From Activist Investors - MSN

Sep 27, 2024
pulisher
Sep 27, 2024

Kiran Mazumdar-Shaw’s niece makes debut at Nasdaq as Bicara Therapeutics goes public - The Financial Express

Sep 27, 2024
pulisher
Sep 26, 2024

With IPO, have the capital and resources for clinical studies: Bicara CEO - The Economic Times

Sep 26, 2024
pulisher
Sep 25, 2024

Bicara Therapeutics Rings the Opening Bell - Nasdaq

Sep 25, 2024
pulisher
Sep 25, 2024

Bicara Therapeutics Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Sep 25, 2024
pulisher
Sep 21, 2024

Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN

Sep 21, 2024
pulisher
Sep 21, 2024

TPG GP A, LLC Acquires New Stake in Bicara Therapeutics Inc - GuruFocus.com

Sep 21, 2024
pulisher
Sep 19, 2024

James E. Flynn Buys 70,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Ra capital executives buy Bicara Therapeutics shares for $32.99m By Investing.com - Investing.com South Africa

Sep 19, 2024
pulisher
Sep 18, 2024

Ra Capital Management, L.P. Purchases 1,833,000 Shares of Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Ra capital executives buy Bicara Therapeutics shares for $32.99m - Investing.com India

Sep 18, 2024
pulisher
Sep 18, 2024

FMR LLC Acquires New Stake in Bicara Therapeutics Inc - Yahoo Finance

Sep 18, 2024
pulisher
Sep 17, 2024

Deerfield entities buy Bicara Therapeutics shares worth $1.26m By Investing.com - Investing.com Australia

Sep 17, 2024
pulisher
Sep 17, 2024

Deerfield entities buy Bicara Therapeutics shares worth $1.26m - Investing.com

Sep 17, 2024
pulisher
Sep 17, 2024

Bicara Therapeutics closes $362m IPO in flurry of biotech listing activity - Yahoo Finance

Sep 17, 2024
pulisher
Sep 17, 2024

Bicara Therapeutics raises $362 million in Nasdaq debut - The Pharma Letter

Sep 17, 2024
pulisher
Sep 16, 2024

MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last? - Scrip

Sep 16, 2024
pulisher
Sep 16, 2024

Bicara Therapeutics Announces Closing of $362 Million - GlobeNewswire

Sep 16, 2024
pulisher
Sep 16, 2024

Bicara Therapeutics Announces Closing of $362 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - StockTitan

Sep 16, 2024
pulisher
Sep 14, 2024

Bicara, MBX Bio lead gainers as biotech trio makes trading debut - MSN

Sep 14, 2024
pulisher
Sep 14, 2024

TPG-backed Bicara Therapeutics shares surge 46% in stellar market debut - MSN

Sep 14, 2024
pulisher
Sep 13, 2024

Biotech IPOs Surge on Debut: Upsized Deals Boost Shares for Drug Developers Tackling Autoimmune Diseases - Share Price India News

Sep 13, 2024
pulisher
Sep 13, 2024

Trio of first-day pops may bode well for biotech IPO window - BioCentury

Sep 13, 2024
pulisher
Sep 13, 2024

Bicara Therapeutics Opens at $26.25 , Upsized IPO Priced at $18 By Investing.com - Investing.com Canada

Sep 13, 2024
pulisher
Sep 13, 2024

2 Life Sciences Cos. Start Trading After Raising $540M Total - Law360

Sep 13, 2024
pulisher
Sep 13, 2024

Bicara Therapeutics Rises 39% in Debut on Nasdaq - MarketWatch

Sep 13, 2024
pulisher
Sep 13, 2024

3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - MedCity News

Sep 13, 2024
pulisher
Sep 13, 2024

Shares of two Mass. biotech IPOs rise on first day of trading - The Business Journals

Sep 13, 2024
pulisher
Sep 13, 2024

Bicara, MBX Bio lead gainers among biotech IPOs (NASDAQ:BCAX) - Seeking Alpha

Sep 13, 2024

Finanzdaten der Bicara Therapeutics Inc-Aktie (BCAX)

Es liegen keine Finanzdaten für Bicara Therapeutics Inc (BCAX) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):